The “Radiopharmaceuticals Market Growth (Status and Outlook) 2022-2029” Study has been added to Data Bridge Market Research’s repository
The "Radiopharmaceuticals Market Growth (Status and Outlook) 2022-2029” Study has been added to Data Bridge Market Research’s repository. A complete discussion about numerous market related topics in this Radiopharmaceuticals Market research report is sure to aid the client in studying the market on competitive landscape. This market analysis offers an examination of a range of segments that are relied upon to witness the quickest development amid the estimate forecast frame. The company profiles of all the key players and brands that are dominating the Radiopharmaceuticals Market with moves like product launches, joint ventures, mergers and acquisitions which in turn is affecting the sales, import, export, revenue and CAGR values are mentioned in the report. This report also gives you an idea about consumer’s demands, preferences, and their altering likings about particular product.
The Radiopharmaceuticals Market report estimates 2022 - 2029 market development trends for industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also performed here. The report analyses some of the challenges this industry may have to face during the growth. This report also discusses about what technologies need to be worked on in order to incentivize future growth, the effects they will have on the market, and how they can be used. Furthermore, Radiopharmaceuticals Market research report also provides a watchful investigation of the current state of the market which covers several market dynamics.
Global Radiopharmaceuticals Market Analysis and Size
Data Bridge Market Research analyses that the radiopharmaceuticals market is expected to undergo a CAGR of 10.40% during the forecast period. This indicates that the market value, which was USD 4.80 billion in 2021, would rocket up to USD 11.69 billion by 2029. “Diagnostic Applications” dominates the application segment of the radiopharmaceuticals market owing to rising incidences of medical ailments such as diabetes that are responsible for making the lower part of the body symptomatic and vulnerable. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Download Exclusive Sample Report PDF (with All Related Graphs & Charts) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-radiopharmaceuticals-market
Nuclear medicine is increasingly being used in the diagnostic imaging and radiotherapy. This has carved the way for the growth of the radiopharmaceuticals market. Nuclear medicine assists in the diagnosing the organs of any kind of pathological condition, especially cancer.
Industry Segmentation:-
By Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine),
By Application (Diagnostic Applications, Therapeutic Applications),
By Procedural Volume Assessment (Diagnostic Procedures, Therapeutic Procedures),
By Source (Nuclear Reactors, Cyclotrons),
By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Others)
Study Coverage:
The report defines, describes, and forecasts the Global Radiopharmaceuticals Market, by technology, application, and region. It also offers a detailed qualitative and quantitative analysis of the market. The report provides a comprehensive review of the major market drivers, restraints, opportunities, and challenges. It also covers various important aspects of the market, which include the analysis of the competitive landscape, market dynamics, market estimates in terms of value, and future trends in the Radiopharmaceuticals Market.
This Radiopharmaceuticals Market research report has several benefits which can be projected to varied aspects of medical device industry. This Radiopharmaceuticals Market report takes into account diverse segments of the market analysis that today's business ask for. In this report, market is segmented based on mainly type, application, and region. The report includes market analysis based on regional as well as global level. Moreover, this Radiopharmaceuticals Market report serves the purpose of validating the information that has been gathered through internal or primary research. The report describes estimations of CAGR values, market drivers and market restraints about the medical device industry which are helpful for businesses in deciding upon numerous strategies.
Competitive Landscape and Radiopharmaceuticals Market Share Analysis
The radiopharmaceuticals market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to radiopharmaceuticals market.
Major Players:-
• Cardinal Health (US)
• General Electric
• Curium (France)
• Lantheus Medical Imaging (US)
• Bayer AG (Germany)
• Bracco Imaging (Italy)
• Eczacýbaþý-Monrol Nuclear Products (Turkey)
• Nordion (Canada)
• Advanced Accelerator Applications (France)
• NTP Radioisotopes (South Africa)
• JSC Isotope (Russia)
• NorthStar Medical Radioisotopes (US)
• Eckert & Ziegler (Germany)
• Braun Melsungen AG (Germany)
• Smith & Nephew plc (Germany)
• Zimmer Biomet (US)
• Hanger Inc. (US)
• Otto Bock Healthcare GmBH (Germany)
Browse More About This Premium Research Report at https://www.databridgemarketresearch.com/reports/global-radiopharmaceuticals-market
Key Benefits of Buying the Report
The report identifies and addresses the key markets for Radiopharmaceuticals Market operations and services, which would help equipment manufacturers and service providers, review the growth in demand.
The report helps system providers understand the pulse of the market and provides insights into drivers, restraints, opportunities, and challenges.
The report will help key players understand the strategies of their competitors better and help the min making better strategic decisions.
Radiopharmaceuticals Market Development and Acquisitions in 2019
• In December 2019, a significant development was accounted for the expansion of radiopharmaceuticals exchange between Curium and Finnish. Curium has accomplished the purchase of Finnish Radiopharmaceuticals Corporation of MAP medical technologies Oy. This merger of MAP Medical will moreover extend Curium’s trail in Europe, rendering straight entrance to Nordic and Baltic realms for its comprehensive holdings of diagnostic resolutions.
FACTORS DRIVING GROWTH IN GLOBAL RADIOPHARMACEUTICALS MARKET:
Increasing incidence of cancer and cardiac ailments:
According to world health organization cancer was responsible for around 8.8million deaths in 2015. It was found that globally 1in 6 deaths is due to cancer. Low income and middle income country is responsible for around 70.0% of total deaths from cancer. 22.0% of cancer deaths is due to the use of tobacco. Hepatitis and human papilloma virus (HPV) are responsible for around 25.0% of cancer cases in low and middle income countries. Treatment was available for more than 90.0% of the high income countries. Lung cancer is responsible for 1.69 million deaths. Liver cancer is responsible for 788,000 deaths, breast cancer is responsible for 571,000 deaths.
According to the national cancer institute 1,735,350 new cases of cancer will be diagnosed in the United States. Based on the 2011-2015 data the number of cases of cancer is 164 per 1000,000 persons. Cancer mortality is higher in men that are 197 per 100,000 men and in women it is 139 per 100,000 women.
According to the international agency for research on cancer there were 14.1 million new cases of cancer in 2012 and it is expected to rise every year that is it is expected to grow to 23.6 million by 2030.
As radio pharmaceuticals are used to treat life threatening disease such as cancer. It is also found that there is fall in death rate by cancer by the use of radiopharmaceuticals. Hence as per the data provided above, the number of case of cancers are expected to increase in future, hence with hike in the cancer patients there will be hike in use of radiopharmaceuticals too, as radio pharmaceuticals are used in the treatment and diagnosis of cancer. Hence this market is expected to grow in future.
Advances in radiotracers and alpha radio immunotherapy-based targeted cancer treatment:
Radioisotopes therapy delivers the radiation directly in to the cancer cells. Radioisotopes are usually given as a capsule, drink or by injecting into the veins. Cancer cells absorb the radioactive substance more than the normal cells hence they receive the higher dose and this leads the cell to die. Depending on what type of cancer, different types of radioisotopes are used. Iodine 131 is used in thyroid cancer and in some rare cancer. Strontium-89 and samarium-153 is used in secondary bone cancer, they helps in reducing pain. Radium-223 is used to treat secondary bone cancer, and this is the new isotope therapy.
Including positron emission tomography (PET) and single photon emission computed tomography (SPECT) is included in molecular radiotracer imaging. This has the tremendous potential in diagnosis of the brain changes. An injection of radiolabeled compound is injected and goes through the regional distribution of the brain can be visualize 3dimentionally by PET or SPECT.
Radio tracers are mostly used in human epilepsy. According to world nuclear association each year 40million of nuclear medicine procedures are performed. And the demand for radioisotopes is increasing by 5.0% annually. Around 10,000 hospitals use radioisotopes in medicines out of which 90.0% of radioisotopes is used for diagnosis. Technetium-99 is the most common radioisotope used with 40million procedures per month accounting for 80.0% of all nuclear medicine procedures worldwide.
According to World health organization 50 million of the peoples have epilepsy and nearly 80.0% of the people with epilepsy lives in low and middle income country.
According to national health survey and national survey for children health in 2014 the rate of epilepsy was 2.3 million in 2014 and that increases to 3 million by 2015. And in 2007 number of children suffering from epilepsy was 450,000 and that increases to 470,000 by 2015.
As per the data provided, the number of cases of cancer and epilepsy are expected to increase at a very higher rate, this means the use for radioisotopes as well as the radiotracers will be increased. This shows that the radiopharmaceuticals market will have a strong growing platform in future.
For More Insights Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-radiopharmaceuticals-market
Healthcare Infrastructure growth Installed base and New Technology Penetration
The radiopharmaceuticals market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for radiopharmaceuticals market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the radiopharmaceuticals market. The data is available for historic period 2010-2020.
Browse More Reports:-
Healthcare and Medical System Integrators Market – Industry Trends and Forecast to 2028
Global Healthcare and Medical System Integrators Market, By Type (Horizontal Integration, Vertical Integration), Application (Government Hospitals, Private Hospitals and Clinics, Healthcare Organizations, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Read More @ https://www.databridgemarketresearch.com/reports/global-healthcare-and-medical-system-integrators-market
Infrared Spectroscopy Market – Industry Trends and Forecast to 2029
Global Infrared Spectroscopy Market, By Product Type (Benchtop IR Spectroscope, IR Microscopy, Portable IR Spectroscope, Hyphenated IR Spectroscope, Terahertz IR Spectroscope), Spectrum (Near Infrared, Far Infrared, Mid Infrared), Application (Pharma and Biotech, Food and Beverages, Environmental Testing, Academics, Security, Industrial, Petrochemicals, Semiconductors, Others), Technology (Dispersive Infrared Spectroscopy and Fourier Transform Infrared (FTIR) Spectroscopy) – Industry Trends and Forecast to 2029
Read More @ https://www.databridgemarketresearch.com/reports/global-infrared-spectroscopy-market
Digital Stethoscope Market – Industry Trends and Forecast to 2027
Global Digital Stethoscope Market By Technology (Wireless Transmission System, Integrated Receiver Head Piece System, Integrated Chest Piece System, Numerical Stimulation, System Integration), Design (Single Head, Double Head, Triple Head), End User (Hospitals, Clinics, Healthcare Institutes, Ambulatory Surgery Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027
Read More @ https://www.databridgemarketresearch.com/reports/global-digital-stethoscope-market
Surgical Instrument Tracking Systems Market – Industry Trends and Forecast to 2029
Global Surgical Instrument Tracking Systems Market, By Type (Pro Sites, Multi Sites), Component (Hardware, Software, Services), Technology (Barcode Tracking, Radio Frequency Identification (RFID), Electronic Tracking, Others), End User (Hospitals, Ambulatory Surgical Centers, Research Centers, Clinics, Others), Distribution Channel (Direct Tender, Third Party Distributor) – Industry Trends and Forecast to 2029
Read More @ https://www.databridgemarketresearch.com/reports/global-surgical-instrument-tracking-systems-market
Medical Exoskeleton Market – Industry Trends and Forecast to 2029
Global Medical Exoskeleton Market, By Component (Hardware, Software), Type (Powered Exoskeleton, Passive Exoskeleton), Mobility (Stationary, Mobile), Extremity (Lower Extremity, Upper Extremity) – Industry Trends and Forecast to 2029
Read More @ https://www.databridgemarketresearch.com/reports/global-medical-exoskeleton-market
Sterilization Equipment Market – Industry Trends and Forecast to 2029
Global Sterilization Equipment Market, By Product and Service (Sterilization Instruments, Sterilization Consumables and Accessories, Sterilization Services), End User (Hospitals and Clinics, Medical Device Companies, Food and Beverage Industry, Pharmaceutical Companies, Others) – Industry Trends and Forecast to 2029.
Read More @ https://www.databridgemarketresearch.com/reports/global-sterilization-equipment-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com